Rinofluimucil (acetylcysteine) nasal spray solution 10 ml. vial

Description

Rinofluimucil (acetylcysteine) nasal spray solution 10 ml. vial

Composition

active substances: 1 ml of the drug contains: acetylcysteine ​​- 10 mg, tuaminoheptane sulfate – 5 mg; auxiliary substances: benzalkonium chloride, hypromellose, disodium edetate, sodium dihydrogen phosphate monohydrate, sodium hydrogen phosphate dodecahydrate, dithiothreitol, sorbitol (E 420), mint flavoring, ethanol 96%, sodium hydroxide, water for injections.

Medicinal form

Nasal spray, solution.

Main physico-chemical properties: almost transparent, colorless solution with a mint aroma.

Pharmacotherapeutic group

Means used in diseases of the nasal cavity.
ATX code. PBX R01A B08.

Pharmacological properties

The drug is used to treat diseases of the nasal cavity in children. It has a pronounced anti-edematous and phlegm-thinning effect. The active components of the drug are acetylcysteine ​​and tuaminoheptane sulfate.
Acetylcysteine ​​effectively reduces the viscosity of sputum. It has a detoxifying, expectorant effect. The principle of action lies in the ability of the substance to affect the glycoproteins of mucus, disrupting their disulfide bond, which leads to its liquefaction. Also, the substance inhibits the activity of leukocytes (their chemotaxis), as a result of which the inflammatory process slows down.
Tuaminoheptane sulfate is an adrenomimetic agent that effectively reduces swelling, hyperemia of the nasal cavity and nasopharynx, constricts blood vessels.

Indications 

The medicine is used in the presence of such conditions:

• acute rhinitis with purulent discharge;
• chronic rhinitis;
• vasomotor rhinitis;
• sinusitis;
• sinusitis (in the complex).

Contraindications

There are a number of contraindications to the use of the drug, among them:

• hyperfunction of the thyroid gland;
• glaucoma (angle-closure);
• the presence of hypersensitivity to the components in the composition of the product.

The drug is carefully prescribed when combining therapy with MAO inhibitors and antidepressants, and within 2 weeks after taking them. Also, you need to consult with your doctor about taking medication for angina pectoris, bronchial asthma, frequent ventricular extrasystoles.

Pregnancy and breastfeeding period

In urgent need, the use of the drug during pregnancy and breastfeeding is possible only on condition of prior consultation with the attending physician.

Mode of application

The drug is used in children, as prescribed by a doctor, intranasally, alternately in each nostril, 1 dose of spray (one press on the cap), 3-4 times a day. This dosage is designed for children from 1 year old. Drug therapy should not be carried out for more than 7 days.
For adults, a dosage is prescribed in the amount of 2 doses (presses) in each nostril, 3-4 times a day. The duration of treatment should not exceed 7 days, in order to avoid the development of addiction symptoms and disorders of the mucous membrane.

Overdose

If the prescribed doses are overestimated, the following conditions may appear:

• tremor;
• tachycardia;
• increased pressure;
• dryness in the nasal passage and in the area of ​​the nasopharynx.

In this case, symptomatic treatment is recommended.
With prolonged use of the drug, the effect of “addiction” develops and the severity of the drug’s action decreases. It is also possible to disturb the mucous membrane of the nasal cavity and sinuses.

Adverse reactions

The use of the drug, quite rarely, may be accompanied by:

• skin rashes;
• increased heart rate;
• increased excitability;
• inflammation of the sebaceous glands;
• increased pressure;
• violation of urination.